FDA Investigator Corrine M Carter

Corrine M Carter has inspections in 3 countries as of 15 Dec 2023. Corrine M Carter has collaborated with a combinined 3295 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
15 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, Denmark, Canada
Akbar J Zaidi, Alanna Lmussawwir Bias, Amanda L Baskin, Andrace Lde Yampert, Andrea A Branche, Andrea D Swingle, Andrew H Paeng, Anthony R Petriella, Anya D Lockett Evans, Ava M Bowman, Azza Talaat, Barbara A Rusin, Bei Y He, Benjamin J Smith, Brandi N Mcgrady, Brian D Garthwaite, Brian M Campbell, Brittany M Lowe, Bruce, Byungja E Marciante, Calvin K Cook, Camille D Brown, Carmen M Faraianu, Caroline H Le, Catherine V Quinlan, CDR Kimberly Y Martin, Charles D Brown, Charles I Ann, Charles L Zhou, Charles M Spyr, Chelsea W Lamm, Cheron M Portee, Cheryl A Fuhs, Cheryl M Monroe, Constantin Y Philopoulos, Cynthia L Aycock, Cynthia Li, Daniel B Bordt, Daniel J Gorski, Danny Tuntevski, Darren S Morgan, David A Paterson, David L Duncan, David Perkins, Dawn C Olenjack, Debara R Reese, Debara Reese, Denise L Burosh, Dennis E Guilfoyle, PhD, Dina A Tallman, Donald C Obenhuber, PhD, Downer, Dr. Abhijit Raha, PhD, Edwardstine J Reese, Elizabeth D Connell, Emest F Bizjak, Emily J Orban, Eric S Pittman, Etty Feller, Everard A Irish, Geneve M Maxwell, Geoffrey K Kilili, Helen B Ricalde, Ifueko Osemwota, James A Lane, James H Robinson, Janice M Hickok, Jasmine Y Wang, Jean Blackston Hill, Jean Blackstone Hill, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Jennifer R Johnson, Joel D Martinez, Johann M Fitch, Joie A Navarrete, Jorge F Christian, Joris Vanloco, Joseph A Piechocki, Joseph R Strelnik, Juliane C Lessard, Karen M Montgomery (KMM), Kathryn Suttling, Kelley L Clark, Kennita Riddick, Kimberly A Dux, Kinh Q Mac, Kristina Nastovski, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Laureen M Geniusz, Lauren E Burke, Lauren E Sexton, Lauren Iacono Connors, PhD, LCDR Anastasia Mpiliafas Brown, Leigh Anne Myers, Lesley Maep Lutao, Leslie A Paul, Lewis K Antwi, Lisa M Bellows, Lisa P Oakes, Lloyd D Payne, Luella J Rossi, Lynda L Lanning, Maira P Brading, Margaret M Annes, Mark G Peterson, Martha Sullivan Mynck, Martha Sullivan Myrick, Martin R Vowell, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Melina Rodriguez Upton, Mercy Oyugi, Merelynn Rhoten, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michelle L Jones, Monica J Wilkins, Monique S Frazier, Montgomery Montgomery, Karen M, Muna Algharibeh, Myra K Casey, Nailing Zhang, Nancy A Bellamy, Natalie A Mickelsen, DVM, Natalie Mickelsen, DVM, Neal D Singletary, PhD, Neali H Lucas, Nicole C Victoria, PhD, Norman Wong, Patricia A Cochran, Patricia H Dlugosz, Patrick B Cummings, Patsy J Domingo, Paula J Perry, Phillip D Waldron, Qiao Y Bobo, Rabin N Ghoshal, Rafeeq A Habeeb, Ralph A Erickson, Raymond T Oji, Rebecca E Dombrowski, Regina T Brown, Robert D Tollefsen, Robert G Taylor, Robert J Ham, Robert M Barbosa, Samson O Oluseye, Sandra A Boyd, Sandra A Hughes, Sandy J Ziegler, Sarah M Meng, Sarah M Napier, Scott B Laufenberg, Sherri J Jackson, Sherrie L Krolczyk, Sidney B Priesmeyer, State Agency, Stephanie Mangigian, MS/OSH, RN, Susan F Laska, MS, Susan P Bruederle, Suyang Qin, Theodore N Sietsema, Thomas J Arista, Thuy T Nguyen, LCDR, Timothy C Schell, Tina M Pawlowski, Tracey Asinjen Wiersma, Travis M Beard, Travis S Bradley, Veronica Bush, Veronica L Bush, Wayne E Seifert, William D Tingley, William G Nelson, William R Brubaker, Yangmin Ning, Yumi J Hiramine

Corrine M Carter's Documents

Publish Date Document Type Title
September, 2016 EIR Cassandra E. Curtis, M.D. - EIR, 2016-09-14
April, 2018 EIR Eli Lilly and Company - EIR, 2018-04-23
September, 2021 EIR Sarah E. Zauber, M.D. - EIR, 2021-09-16
March, 2023 FDA 483 Kathleen N. Moore, M.D. - Form 483, 2023-03-17
March, 2020 EIR Labcorp Drug Development Inc. - EIR, 2020-03-13
July, 2015 FDA 483 Med-Mizer, Inc. - Form 483, 2015-07-06
April, 2018 FDA 483 Eli Lilly and Company - Form 483, 2018-04-23
May, 2019 FDA 483 Shadia I. Jalal, M.D. - Form 483, 2019-05-17
September, 2015 FDA 483 Dr. Mahendra Sanapati, MD - Form 483, 2015-09-18
August, 2023 FDA 483 Miguelangelo J. Perez-Cruet, M.D., M.S. - Form 483, 2023-08-25
July, 2016 FDA 483 Response David A. Plager, M.D. - Form 483R, 2016-08-12
July, 2015 FDA 483 Response Med-Mizer, Inc. - Form 483R, 2015-07-20
September, 2015 EIR Dr. Mahendra Sanapati, MD - EIR, 2015-09-18
December, 2015 FDA 483 Cindy M. Basinski, MD - Form 483, 2015-12-03
October, 2019 FDA 483 Parham A. Mokri M.D. - Form 483, 2019-10-28
September, 2016 FDA 483 Cassandra E. Curtis, M.D. - Form 483, 2016-09-14
November, 2016 FDA 483 David C. Delgado, M.D. - Form 483, 2016-11-03
July, 2016 EIR Sina Moainie, M.D. - EIR, 2016-07-18
February, 2019 FDA 483 Franciscan Health IRB - Form 483, 2019-02-13
September, 2017 FDA 483 Jeffrey Kline - Form 483, 2017-09-06
August, 2022 FDA 483 Labcorp Drug Development Inc. - Form 483, 2022-08-12
September, 2021 FDA 483 Sarah E. Zauber, M.D. - Form 483, 2021-09-16
July, 2016 FDA 483 David A. Plager, M.D. - Form 483, 2016-07-27
February, 2016 EIR Concentrics Research, LLC - EIR, 2016-02-24
August, 2018 FDA 483 Inotiv, Inc - Form 483, 2018-08-03
September, 2022 FDA 483 University Of Michigan - IRBMED - Form 483, 2022-09-02
September, 2016 FDA 483 Response Cassandra E. Curtis, M.D. - Form 483R, 2016-10-04
May, 2023 FDA 483 Veronique Sebastian, M.D. - Form 483, 2023-05-25
May, 2022 FDA 483 Saint Bernards Medical Center IRB - Form 483, 2022-05-26
September, 2018 EIR David A. Plager, M.D. - EIR, 2018-09-18
December, 2017 EIR Erik A. Imel, M.D. - EIR, 2017-12-14
July, 2016 FDA 483 Sina Moainie, M.D. - Form 483, 2016-07-18
October, 2020 FDA 483 Joseph Thaddeus Beck, MD - Form 483, 2020-10-02
September, 2015 FDA 483 Response Dr. Mahendra Sanapati, MD - Form 483R, 2016-01-18
July, 2016 EIR David A. Plager, M.D. - EIR, 2016-07-27
August, 2022 EIR Labcorp Drug Development Inc. - EIR, 2023-11-06

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more